Consistently, HA22T cells, another highly invasive HCC cell line commonly used in chemo-resistance studies also exhibited a significantly higher subG1 population following YULINK knockdown than scramble controls under 12-h glucose restriction conditions (Supplementary Figure S2). The gene discussed is MIOS; the disease is hepatocellular carcinoma.